Pacific Edge Limited (PEB)-Product Pipeline Analysis, 2016 Update

Pacific Edge Limited (PEB)-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME14742PD
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. The company has completed trials in colorectal cancer prognosis and bladder cancer detection. It identifies gene and protein signatures for the development of cancer management tools. PEB's cxbladder is a non-invasive laboratory test for the detection of bladder cancer. The company is developing prognostic gene signature for patients, who are diagnosed with stage II or stage III colorectal cancer. It is also building a range of cxbladder tests to meet different clinical needs. The company provides diagnostic services through its facilities in New Zealand, Spain, Australia and the US. P

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Pacific Edge Limited

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Pacific Edge Limited Company Snapshot 6

Pacific Edge Limited Company Overview 6

Pacific Edge Limited Pipeline Products and Clinical Trials Overview 7

Pacific Edge Limited-Pipeline Analysis Overview 9

Key Facts 9

Pacific Edge Limited-Major Products and Services 10

Pacific Edge Limited Pipeline Products by Development Stage 11

Pacific Edge Limited Clinical Trials by Trial Status 13

Pacific Edge Limited Pipeline Products Overview 14

Cxbladder 14

Cxbladder Product Overview 14

Cxbladder-Health 15

Cxbladder-Health Product Overview 15

Cxbladder-Prognosis Assay 16

Cxbladder-Prognosis Assay Product Overview 16

Cxbladder Monitor 17

Cxbladder Monitor Product Overview 17

Cxbladder Monitor Clinical Trial 18

Cxbladder Predict 19

Cxbladder Predict Product Overview 19

CxColorectal 20

CxColorectal Product Overview 20

Cxcolorectal-prognosis Gen II 21

Cxcolorectal-prognosis Gen II Product Overview 21

Diagnostic Assay-Gastric Cancer 22

Diagnostic Assay-Gastric Cancer Product Overview 22

Endometrial Cancer Detection Assay 23

Endometrial Cancer Detection Assay Product Overview 23

Gastric Cancer Triage Immunoassay 24

Gastric Cancer Triage Immunoassay Product Overview 24

Prognostic Assay-Melanoma 25

Prognostic Assay-Melanoma Product Overview 25

Pacific Edge Limited-Key Competitors 26

Pacific Edge Limited-Key Employees 27

Pacific Edge Limited-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Pacific Edge Limited, Recent Developments 29

May 16, 2016: Pacific Edge Presents Positive Cxbladder Monitor Results 29

May 25, 2015: Research Shows Pacific Edge's Cxbladder Detect Outperforms Other Non-Invasive Bladder Cancer Diagnostics 29

May 19, 2015: Pacific Edge's Cxbladder Triage Accurately Stratifies Patients with Bladder Cancer Symptoms but Low Probability of Bladder Cancer 30

Apr 21, 2015: Pacific Edge seeks additional laboratory accreditation as it pursues international opportunities 30

Mar 18, 2015: Pacific Edge Adds To Its Growing List Of Issued Patents 31

Mar 18, 2015: Cxbladder Triage To Be Showcased In Prestigious Medical Journal 31

Nov 28, 2014: Pacific Edge Reports Commercial Progress and Revenue Growth 32

Nov 26, 2014: Europe Grants Pacific Edge Patent For Colorectal Cancer Prognostic Technology 33

Nov 13, 2014: Pacific Edge announces appointment of Chief Financial Officer 34

Sep 04, 2014: U.S. Grants Pacific Edge Patent for Melanoma Detection 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Pacific Edge Limited Pipeline Products by Equipment Type 8

Pacific Edge Limited Pipeline Products by Development Stage 11

Pacific Edge Limited Clinical Trials by Trial Status 13

List of Tables

Pacific Edge Limited Pipeline Products and Clinical Trials Overview 7

Pacific Edge Limited Pipeline Products by Equipment Type 7

Pacific Edge Limited Pipeline Products by Indication 8

Pacific Edge Limited Clinical Trials by Trial Status 8

Pacific Edge Limited, Key Facts 9

Pacific Edge Limited, Major Products and Services 10

Pacific Edge Limited Number of Pipeline Products by Development Stage 11

Pacific Edge Limited Pipeline Products Summary by Development Stage 12

Pacific Edge Limited Clinical Trials by Trial Status 13

Pacific Edge Limited Clinical Trials Summary 13

Cxbladder-Product Status 14

Cxbladder-Product Description 14

Cxbladder-Health-Product Status 15

Cxbladder-Health-Product Description 15

Cxbladder-Prognosis Assay-Product Status 16

Cxbladder-Prognosis Assay-Product Description 16

Cxbladder Monitor-Product Status 17

Cxbladder Monitor-Product Description 17

Cxbladder Monitor-A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC) 18

Cxbladder Predict-Product Status 19

Cxbladder Predict-Product Description 19

CxColorectal-Product Status 20

CxColorectal-Product Description 20

Cxcolorectal-prognosis Gen II-Product Status 21

Cxcolorectal-prognosis Gen II-Product Description 21

Diagnostic Assay-Gastric Cancer-Product Status 22

Diagnostic Assay-Gastric Cancer-Product Description 22

Endometrial Cancer Detection Assay-Product Status 23

Endometrial Cancer Detection Assay-Product Description 23

Gastric Cancer Triage Immunoassay-Product Status 24

Gastric Cancer Triage Immunoassay-Product Description 24

Prognostic Assay-Melanoma-Product Status 25

Prognostic Assay-Melanoma-Product Description 25

Pacific Edge Limited, Key Employees 27

Pacific Edge Limited, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Rubicon Ltd.

Metlifecare Limited

Fisher & Paykel Healthcare Corporation Limited

Pacific Edge Limited, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 53910
Site License
USD 1500 INR 107820
Corporate User License
USD 2250 INR 161730



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]